More BS from the CDC Bioweapons Lab at UCal Irvine/Davis To: zerhoune@od.nih.gov, SpinLyme@yahoogroups . com ,
kshepard@calea.org, fitzmas@gmail . com , patrick.fitzgerald@usdoj.gov,
modelt1918@sbcglobal . net , jdrazen@nejm.org, letters@courant . com ,
Jgerberding@cdc.gov, lender@courant . com , michael.cole@po.state.ct.us,
conndcj@po.state.ct.us, executive-editor@nytimes . com , managing-
editor@nytimes . com , news-tips@nytimes . com , the-arts@nytimes . com ,
bizday@nytimes . com , foreign@nytimes . com , metro@nytimes . com ,
national@nytimes . com , dvbid@cdc.gov, brigidcallahan@optonline . net ,
trvl@hotmail . com , ubinas@courant . com , mas1@concentric . net ,
campbell@courant . com , jhornberger@fff.org, thomas.carson@usdoj.gov,
thomas.ryan@po.state.ct.us, kurtzh@washpost . com ,
georgewill@washpost . com , horgan@courant . com ,
commissioner.dcf@po.state.ct.us, cohencolumn@aol . com ,
FalNields@aol . com , bransfield@comcast . net , vtsherr@comcast . net ,
oca@po.state.ct.us, dand@davila-dilzer . com ,
scott.murphy@po.state.ct.us, governor.rell@po.state.ct.us,
attorney.general@po.state.ct.us, randall.samborn@usdoj.gov
Cc: francam@ucia.gov, dr-ahmadinejad@president.ir,
eugenerobinson@washpost . com , horgan@courant . com ,
bmiller@newstimes . com , trvl@hotmail . com , rastro18@aol . com ,
billcurryct@gmail . com , thomas.carson@usdoj.gov, amcguigan@rms-law . com ,
rjmurzyn@aol . com , paulcraigroberts@yahoo . com ,
sidney_blumenthal@yahoo . com , criminal.division@usdoj.gov,
karla.dobinski@usdoj.gov, christopher.christie@usdoj.gov
Subject: More BS from the CDC Bioweapons Lab at UCal Irvine/Davis
Date: Apr 17, 2008 8:13 PM
More BS from the CDC Bioweapons Lab at UCal Irvine/Davis below.
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D
The mouse-brain model is a bad model for human Lyme brain:
* w w w .actionlyme.org/LYME_IS_A_PERMANENT_BRAIN_INFECTION.htm
Recovery from the spheroplast form to intact spirochetes can take
months:
* w w w .actionlyme.org/IDSA_JOHNSONCULTURING.htm
IDSA is aware that the spheroplast form reverts back into intact
spirochetes, since
all the crooks have cited David Nelson's report:
* w w w .actionlyme.org/BOGUS_RUSSIAN_NYMC_ARTICLES.htm
* w w w .actionlyme.org/IDSA_CYST_VIABLE.htm
We're simply not putting up with this relentless bullshit.
There certainly is a ton of "Lyme" in California.
Go to the taxonomy database and see how many "CA" strains of borrelia
there are:
* w w w .actionlyme.org/HOW_RICO_WILL_BE_CHARGED.htm
How many are there?
30?
* w w w .ncbi.nlm.nih.gov/Taxonomy/Browser/w w w tax.cgi?id=3D138
No one cares if the disease (permanent brain infection) they have is
from -burgdorferi
or -outer mongolii or -frenchfrii or -barbouri or -gimmeabreakii.
Besides, Brian Fallon already clinched it:
* w w w .actionlyme.org/FALLON_DANGEROUS_TERRORIST.htm
His patients relapsed, too, because the disease is really relapsing
fever.
Perhaps one day some researchers from, oh, say, the Czech Republic can
tell us all
about it.
Oh. They already did:
* w w w .ncbi.nlm.nih.gov/pubmed/18345249?ordinalpos=3D4&itool=3DEntrezSys=
tem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Background: Borrelia burgdorferi sensu lato is a group of at least
twelve closely
related species some of which are responsible for Lyme disease, the
most frequent
zoonosis in Europe and the USA. Many of the biological features of
Borrelia are
unique in prokaryotes and very interesting not only from the medical
viewpoint but
also from the view of molecular biology. Methods: Relevant recent
articles were
searched using PubMed and Google search tools. Results and Conclusion:
***This is
a review of the biological, genetic and physiological features of the
spirochete
species group, Borrelia burgdorferi sensu lato. In spite of a lot of
recent articles
focused on B. burgdorferi sensu lato, many features of Borrelia
biology remain obscure.***
It is one of the main reasons for persisting problems with prevention,
diagnosis
and therapy of Lyme disease. The aim of the review is to summarize
ongoing current
knowledge into a ***lucid and comprehensible form.***
ENOUGH of this BULL SHIT from the biggest bullshitters in the world.
The CDC.
Kathleen M. Dickson
* w w w .actionlyme.org
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D
* w w w .insidebayarea . com /sanmateocountytimes/localnews/ci_8956433
Lyme bacteria can 'hide' from medicine, study says
Behavior may help explain symptoms after treatment
By Suzanne Bohan, STAFF WRITER
Article Created: 04/17/2008 02:34:00 AM PDT
A recent study from the University of California, Davis, provides the
first evidence
that the bacteria causing Lyme disease can evade antibiotics by
"hiding out"
in tissue throughout the body and remain infectious long after
treatment ends.
"Lyme disease is a tough nut to crack," said Stephen Barthold, the
study's
lead researcher and director of the university's Center for
Comparative Medicine.
"The bacterium causing Lyme disease has evolved to evade the body's
immune
system, so it's not surprising that it can also evade antibiotics."
The study found the hidden bacteria, however, appeared dormant,
although it still
produced proteins potentially capable of continuing Lyme disease
symptoms, he said.
The article appeared in the March issue of the journal Antimicrobial
Agents and
Chemotherapy, and the research was funded by the National Institutes
of Health.
The findings provide critical data in the quest to offer relief for
those certain
they're suffering from the sometimes crippling symptoms of Lyme
disease years
after their initial infection and subsequent treatment. Patients with
these chronic
symptoms often report joint inflammation and arthritis, memory loss,
mood changes
and sleep disorders, among other health problems.
Some also fear they face a similar fate as those with untreated Lyme
disease =97 including
carditis, also called heart inflammation, and nerve damage.
The Centers for Disease Control and Prevention lists Northern
Advertisement
California as an active region for Lyme disease transmission, although
it's
most prevalent in the Northeastern and Great Lake states. The bacteria
are spread
primarily by Western black-legged ticks in California and deer ticks
in other regions
of the country.
"There's no doubt about it, it's here," Barthold said. But in
a novel ecological twist, when young ticks feed on a certain species
of lizard,
something in the lizard's blood clears the Lyme disease-causing
bacteria from
the tick, so most adult ticks in California aren't infectious.
Barthold said
it's a key reason for the region's lower rate.
While some patients and their doctors advocate continued use of
antibiotics for
weeks, months or even years to combat the condition, the CDC and other
major medical
organizations state that evidence doesn't support more than two rounds
of antibiotics,
and that more aggressive treatment can prove harmful.
That leaves those with chronic symptoms long after initial treatment
paying costly
bills should they pursue continued antibiotic administration. Many
insurers decline
to cover long-term treatment for the condition, citing a lack of
proven effectiveness.
Patients also report coping with anxiety and frustration over the
limited medical
options available to them for relieving their symptoms. Numerous Lyme
disease advocacy
groups have formed to call for better diagnosis and treatment
protocols.
The UC Davis researchers infected three groups of mice with Borrelia
burgdorferi,
the bacteria that causes Lyme disease. Mice showed comparable symptoms
of Lyme disease
as humans and responded similarly to antibiotic treatment.
One group of mice received antibiotics during the first three weeks of
infection,
while another got antibiotics four months later. The third group
received only a
placebo.
When the treatments were completed, the placebo group showed continued
infection
in a standard lab test, while the two antibiotics groups showed no
trace of the
bacteria using the same test.
Nonetheless, researchers still found small numbers of Borrelia
persisting in collagen-rich
tissue in the antibiotic-treated mice that the lab tests missed.
Collagen, a connective
tissue, is found throughout the body, including in the skin,
ligaments, tendons
and the heart muscle. Barthold said it requires a tissue sample to
find any hidden
bacteria.
"It's an invasive procedure the medical practice simply doesn't do,"
he said.
In addition, ticks that fed on the antibiotic-treated mice still
picked up the Lyme
disease bacteria and transferred them to uninfected mice. These mice,
however, didn't
develop Lyme disease, since the hidden bacteria doesn't replicate like
normal
bacteria.
Testing in doctors' offices for this elusive type of Borrelia would
provide
limited value at this stage, Barthold added, since there's no known
way to clear
it out. He agrees with CDC guidelines warning against long-term
antibiotic treatment.
"If the first round of antibiotics hasn't eliminated them, it's not
likely that a longer regimen of antibiotics would be any more
successful,"
Barthold said. "It's more likely that a completely different class of
antibiotics
would be needed to accomplish that."
But the findings do provide another explanation for the persistent
symptoms reported
by those treated for Lyme disease, particularly people who didn't
swiftly get
antibiotics following an infection.
Barthold said it appears these elusive Borrelia don't replicate, and
instead
remain dormant, as microbes causing herpes, tuberculosis and syphilis
often do.
He said it is unknown at this stage if these Borrelia may re-emerge
and cause recurrent
disease, although that's an area he and others intend to study.
But the nondividing Borrelia could release proteins that "may elicit
continued
symptoms in Lyme disease patients," he said.
Barthold said he sympathizes with those coping with chronic symptoms
following a
Lyme disease infection.
"Everybody wants an answer, and I don't blame them," he said.
For now, Barthold said the crucial result of his study is its role in
creating an
animal model that will allow researchers to study a variety of
antibiotic treatments
that eliminate even the hidden Borrelia, which ideally would one day
work on humans
as well.
"We can use that animal model =97 to test other antibiotic modalities,
and as
the best way to completely cure them of their infection," Barthold
said.
Reach Suzanne Bohan at sbohan@bayareanewsgroup . com or 650-348-4324.
Print Email Return to Top
Comments
Please keep your comments respectful of others by avoiding name-
calling and other
inappropriate remarks.
FAQ: About article commenting
Recent Commentsht